Effect of miR-21 on Renal Fibrosis by Regulating MMP-9 and TIMP1 in kk-ay Diabetic Nephropathy Mice

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 537-546

  Wang, Jinyang ^a,b   Gao, Yanbin ^a   Ma, Mingfei ^c   Li, Minzhou ^c   Zou, Dawei ^a   Yang, Jinkui ^b   Zhu, Zhiyao ^a   Zhao, Xuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

ACR; Ccr; Diabetic nephropathy; ECM; miRNA; MMP 9 and TIMP 1

Indexed keywords

MUS;

COLLAGEN TYPE 4; CREATINE; FIBRONECTIN; GELATINASE B; MICRORNA; MIRN21 MICRORNA, MOUSE; TIMP1 PROTEIN, MOUSE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALBUMINURIA; ANIMAL; ARTICLE; C57BL MOUSE; DIABETIC NEPHROPATHY; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; MALE; METABOLISM; MOUSE; PATHOLOGY; URINE;

ALBUMINURIA; ANIMALS; COLLAGEN TYPE IV; CREATINE; DIABETIC NEPHROPATHIES; FIBRONECTINS; FIBROSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICRORNAS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84886590520     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9539-2     Document Type: Article

References (39)

1. Rychlik, I., Miltenberger-Miltenyi, G., & Ritz, E. (1998). The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. Nephrology, Dialysis, Transplantation, 13(Suppl 8), 6-10.
2. Tervaert, T. W., Mooyaart, A. L., Amann, K., et al. (2010). Pathologic classification of diabetic nephropathy. Journal of the American Society of Nephrology, 21, 556-563.
3. Mason, R. M., & Wahab, N. A. (2003). Extracellular matrix metabolism in diabetic nephropathy. Journal of the American Society of Nephrology, 14, 1358-1373.
4. Ito, T., Tanimoto, M., Yamada, K., et al. (2006). Glomerular changes in the KK-Ay/Ta mouse: A possible model for human type 2 diabetic nephropathy. Nephrology (Carlton), 11, 29-35.
5. Perron, M. P., & Provost, P. (2008). Protein interactions and complexes in human microRNA biogenesis and function. Frontiers in Bioscience, 13, 2537-2547.
6. Poy, M. N., Eliasson, L., Krutzfeldt, J., et al. (2004). A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 432, 226-230.
7. Kloosterman, W. P., Lagendijk, A. K., Ketting, R. F., et al. (2007). Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biology, 5, e203.
8. El Ouaamari, A., Baroukh, N., Martens, G. A., et al. (2008). miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes, 57, 2708-2717.
9. Tang, X., Muniappan, L., Tang, G., et al. (2009). Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA, 15, 287-293.
10. He, A., Zhu, L., Gupta, N., et al. (2007). Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Molecular Endocrinology, 21, 2785-2794.
11. Qin, W., Chung, A. C., Huang, X. R., et al. (2011). TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. Journal of the American Society of Nephrology, 22, 1462-1474.
12. Chung, A. C., Huang, X. R., Meng, X., et al. (2010). miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. Journal of the American Society of Nephrology, 21, 1317-1325.
13. Wang, Q., Wang, Y., Minto, A. W., et al. (2008). MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB Journal, 22, 4126-4135.
14. Zhang, Z., Luo, X., Ding, S., et al. (2012). MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Letters, 586, 20-26.
15. Shantikumar, S., Caporali, A., & Emanueli, C. (2012). Role of microRNAs in diabetes and its cardiovascular complications. Cardiovascular Research, 93, 583-593.
16. Moriyama, T., Ohuchida, K., Mizumoto, K., et al. (2009). MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Molecular Cancer Therapeutics, 8, 1067-1074.
17. Gabriely, G., Wurdinger, T., Kesari, S., et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Molecular and Cellular Biology, 28, 5369-5380.
18. Roy, S., Khanna, S., Hussain, S. R., et al. (2009). MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovascular Research, 82, 21-29.
19. Meng, F., Henson, R., Wehbe-Janek, H., et al. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
20. Li, H. Y., Hou, F. F., Zhang, X., et al. (2007). Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. Journal of the American Society of Nephrology, 18, 528-538.
21. Miyazaki, T., Aoyama, I., Ise, M., et al. (2000). An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrology, Dialysis, Transplantation, 15, 1773-1781.
22. Nuovo, G. J. (2008). In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods, 2008(44), 39-46.
23. Schmittgen, T. D., Lee, E. J., Jiang, J., et al. (2008). Real-time PCR quantification of precursor and mature microRNA. Methods, 44, 31-38.
24. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, 2001(29), e45.
25. Viberti, G., & Wheeldon, N. M. (2002). Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect. Circulation, 106, 672-678.
26. Fioretto, P., & Mauer, M. (2010). Diabetic nephropathy: Diabetic nephropathy-challenges in pathologic classification. Nature Reviews Nephrology, 6, 508-510.
27. Krolewski, A. S., Canessa, M., Warram, J. H., et al. (1988). Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. New England Journal of Medicine, 318, 140-145.
28. Ballard, D. J., Humphrey, L. L., Melton, L. J., 3rd, et al. (1988). Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes, 37, 405-412.
29. Krichevsky, A. M., & Gabriely, G. (2009). miR-21: A small multi-faceted RNA. Journal of Cellular and Molecular Medicine, 13, 39-53.
30. Zarjou, A., Yang, S., Abraham, E., et al. (2011). Identification of a microRNA signature in renal fibrosis: Role of miR-21. American Journal of Physiology: Renal Physiology, 301, F793-F801.
31. Chau, B. N., Xin, C., Hartner, J., et al. (2012). MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Science Translational Medicine, 4, 121ra118.
32. Chen, S., Hong, S. W., Iglesias-de la Cruz, M. C., et al. (2001). The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Renal Failure, 2001(23), 471-481.
33. Davis, B. N., Hilyard, A. C., Lagna, G., et al. (2008). SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 454, 56-61.
34. Zhang, Z., Peng, H., Chen, J., et al. (2009). MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Letters, 583, 2009-2014.
35. Snoek-van Beurden, P. A., & Von den Hoff, J. W. (2005). Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques, 2005(38), 73-83.
36. Suminoe, A., Matsuzaki, A., Hattori, H., et al. (2007). Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement. Leukemia Research, 31, 1437-1440.
37. Bai, Y., Wang, L., Li, Y., et al. (2006). High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cellular Physiology and Biochemistry, 17, 57-68.
38. Liu, G., Friggeri, A., Yang, Y., et al. (2010). miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. Journal of Experimental Medicine, 207, 1589-1597.
39. Thum, T., Gross, C., Fiedler, J., et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980-984.